hepurposeofthisreportwastoupdatethe2006InternationalLeagueAgainstEpilepsy(ILAE)reportandidentifythelevelofevidenceforlong-termefficacyoreffectivenessforantiepilepticdrugs(AEDs)asinitialmonotherapyforpatientswithnewlydiagnosedoruntreatedepilepsy.AllapplicablearticlesfromJuly2005untilMarch2012wereidentified,evaluated,andcombinedwiththepreviousysis(Glauseretal.,2006)toprovideacomprehensiveupdate.
Thepriorysismethodologywasutilizedwiththreemodifications:(1)thedetectablenoninferiorityboundaryapproachwasdroppedandbothfailedsuperioritystudiesandprespecifiednoninferioritystudieswereyzedusinganoninferiorityapproach,(2)thedefinitionofanadequatecomparatorwasclarifiedandnowincludesanabsoluteminimumpointestimateforefficacy/effectiveness,and(3)therelationshiptablebetweenclinicaltrialratings,levelofevidence,andconclusionsnolongerincludesarecommendationcolumntoreinforcethatthisreviewofefficacy/evidenceforspecificseizuretypesdoesnotimplytreatmentrecommendations.
Thisevidencereviewcontainsoneclarification:ThecommissionhasdeterminedthatclassIsuperioritystudiescanbedesignedtodetectuptoa20?solute(ratherthanrelative)differenceinthepointestimateofefficacy/effectivenessbetweenstudytreatmentandcomparatorusinganintent-to-treatysis.SinceJuly,2005,threeclassIrandomizedcontrolledtrials(RCT)and11classIIIRCTshebeenpublished.Thecombinedysis(1940-2012)nowincludesatotalof64RCTs(7withclassIevidence,2withclassIIevidence)and11meta-yses.
Newefficacy/effectivenessfindingsincludethefollowing:levetiracetamandzonisamidehelevelAevidenceinswithpartialonsetseizuresandbothethosuximideandvalproicacidhelevelAevidenceinchildrenwithchildhoodabsenceepilepsy.
Therearenomajorchangesinthelevelofevidenceforanyothersubgroup.LevetiracetamandzonisamidejoincarbamazepineandphenytoinwithlevelAefficacy/effectivenessevidenceasinitialmonotherapyforswithpartialonsetseizures.AlthoughethosuximideandvalproicacidnowhelevelAefficacy/effectivenessevidenceasinitialmonotherapyforchildrenwithabsenceseizures,therecontinuestobeanalarminglackofwelldesigned,properlyconductedepilepsyRCTsforpatientswithgeneralizedseizures/epilepsiesandinchildreningeneral.
Thesefindingsreinforcetheneedformulticenter,multinationaleffortstodesign,conduct,andyzefutureclinicallyrelevantadequatelydesignedRCTs.Whenselectingapatient'sAED,allrelevantvariablesandnotjustefficacyandeffectivenessshouldbeconsidered.
查看信源地址
编辑:jiang- 2022-05-10阿斯利康的;还有药物Qtrilmet获得欧盟批准,用于II型糖尿病
- 2022-04-25癫痫可以化疗吗
- 2022-04-13预测癫痫患者再入院风险
- 2022-04-12CSP2016:李凌江教授谈论了与应激创伤障碍相关的问题
- 2022-04-11罕见病例:自发性颞极性扩张伴癫痫发作
- 2022-04-11治疗类风湿性关节炎/膝骨关节炎的专家共识
- 预测癫痫患者再入院风险
- CSP2016:李凌江教授谈论了与应激创伤障碍相关的问题
- 罕见病例:自发性颞极性扩张伴癫痫发作
- 治疗类风湿性关节炎/膝骨关节炎的专家共识
- 癫痫治疗障碍仍难以克服
- 桥本氏甲状腺炎的病因是这样的——为什么他们的免疫力会错误地攻击甲状腺
- 癫痫患者停药问题解决了吗?最新的预测模型已经发布!
- 治疗细菌性炎 6食谱防治效果好(2)
- 为什么医生在准备怀孕时建议做?B超检?当然是有原因的!
- 乳腺癌的早期症状
- 月经性癫痫患者妊娠期癫痫控制更好
- 每个女人都是江湖……
- A&R: Semaphorin3B 在血清诱导的关节炎模型中发挥核心作用,减少类风湿性关节炎患者
- 十个女人,八个贫血,五种常见的便宜货,让你充满气血
- 中国还是成立新的疾控机构?大疾控局呼之欲出
- JAMA:阳性结果的文章一定更受关注吗?
- NICE推荐将Elmiron(戊糖多钠)治疗膀胱疼痛综合征
- 新的感染控制方案可显著减少儿童术后胸骨伤口感染
- 抗癫痫药物预防新发癫痫:任重而道远
- 2013国际抗癫痫联合会抗癫痫药用指南
- 基层注意,中药颗粒以后不能随意打开
- 为什么要定期复查脑电图?
- 每四个女人就有一个子宫肌瘤。这个肿瘤有多可怕?
- 乳腺癌的早期症状 预防乳腺癌的几种方法
- Neurology:颅脑损伤增加了迟发性癫痫的风险,高损伤频率、重伤、老年人尤其是
- 染发有什么危害 喜欢掉头发的原因
- 害羞┃做女孩太难了!乳晕是粉色的好女孩?
- 中风癫痫病怎么治疗比较快
- 治疗癫痫病法则那个好
- 癫痫病的病症主要是什么
- 脑外伤癫痫好不好病人?
- 根治癫痫病的分析方法都有什么
- 癫痫病是什么原因过渡到的
- 癫痫病吃掉什么药好点
- 为什么成年人癫痫病难以治愈
- 青少年得癫痫病的致病是什么
- 如何判断影像无异常的癫痫源自区的呢?
- 怎样服用癫痫药剂可以降低副反应
- 年青人癫痫病怎么治疗最彻底
- 原发癫痫病能康复吗